HLN · Pharma and healthcare · one day
Haleon (HLN): news on Sunday 1 November 2026
News from the 24 hours to Sunday morning, 1 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on a reduction in Haleon's growth guidance and what it means for the investment case, which tilts the tone negative. A second piece offered general commentary on the latest trading session without clear direction.
What drove it
- lowered growth guidance
- investor narrative reassessment
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Mon 26 Oct | −1.2 | 3 |
| Tue 27 Oct | +4.2 | 2 |
| Wed 28 Oct | +1.3 | 5 |
| Thu 29 Oct | +5.7 | 5 |
| Fri 30 Oct | −10.0 | 70 |
| Sat 31 Oct | −5.2 | 9 |
| Sun 1 Nov | −3.5 | 2 |
2 stories · 2 headlines · strongest first
Pharma and healthcare on 1 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Haleon lowers its 2026 growth outlook following soft third quarter −10.01 headline today · 55 in all, since 30 October · A piece asks how the cut to growth guidance affects Haleon's investment narrative. | ||
| −6.3 | Lowered outlook for expansion prompts investors to reassess the company's story, mildly negative.} | |
| Haleon market relevance commentary +0.51 headline today · A piece asks why Haleon matters after the latest session. | ||
| +0.5 | Generic session commentary about the shares with no clear positive or negative news. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Haleon: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.